Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … – Business Wire (Press Release)
Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … – Business Wire (press release)
|
Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge …
Business Wire (press release) Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of … Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … |
Alcoholism Methadone – Google News
Related Alcoholism Methadone Information…